Cargando…
Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics
Although dietary, genetic, or disease-related excesses in urate production may contribute to hyperuricemia, impaired renal excretion of uric acid is the dominant cause of hyperuricemia in the majority of patients with gout. The aims of this review are to highlight exciting and clinically pertinent a...
Autores principales: | Terkeltaub, Robert, Bushinsky, David A, Becker, Michael A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226109/ https://www.ncbi.nlm.nih.gov/pubmed/16820043 http://dx.doi.org/10.1186/ar1909 |
Ejemplares similares
-
Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009) -
Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition
por: Zhao, Ping, et al.
Publicado: (2017) -
Corrigendum to “Pharmacological Basis for Use of Selaginella moellendorffii in Gouty Arthritis: Antihyperuricemic, Anti-Inflammatory, and Xanthine Oxidase Inhibition”
por: Zhao, Ping, et al.
Publicado: (2018) -
Antihyperuricemic Effect of Urolithin A in Cultured Hepatocytes and Model Mice
por: Adachi, Shin-ichi, et al.
Publicado: (2020) -
Antihyperuricemic Effect of Dendropanax morbifera Leaf Extract in Rodent Models
por: Lee, Dongho, et al.
Publicado: (2021)